Hijaz BA, Braun N, Reynolds K, Semenov YR, et al. Nivolumab/relatlimab-associated cutaneous immune-related adverse events in patients treated for advanced melanoma: A multi-center retrospective cohort study. J Am Acad Dermatol 2025 Feb 28:S0190-9622(25)00377.
PMID: 40024392